PINC Research is bullish on Glenmark Pharma and has recommended accumulate rating on the stock with a target of Rs 343 in its January 30, 2012 research report.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!